Skip to content

Erasca, Inc. ERAS Book value per share

Book value per share at other companies

Eli Lilly logo
Eli LillyLLY
$34.82+98.9%
Pfizer logo
PfizerPFE
$15.72-0.6%
Amgen logo
AmgenAMGN
$16.89+47.2%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$7.57-31.5%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$2.73+80.4%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$3.75+93.9%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$4.25B+1,196%
Enterprise value$4.25B+1,265%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Calculated from Erasca, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Erasca, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Erasca, Inc.'s book value per share?
Erasca, Inc. (ERAS) reported book value per share of $1.29 in Q1 2026.
How has Erasca, Inc.'s book value per share changed year-over-year?
Erasca, Inc.'s book value per share decreased by 8.3% year-over-year, from $1.41 to $1.29.
What is the long-term trend for Erasca, Inc.'s book value per share?
Over 5 years (2020 to 2025), Erasca, Inc.'s book value per share has grown at a -26.7% compound annual growth rate (CAGR), from -$5.42 to $1.15.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.